Hepatitis Antivirals (Quiz4) Flashcards

(37 cards)

1
Q

structure of Hep A

A

+ssRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

structure of Hep C

A

+ssRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

structure of Hep B

A

dsDNA with reverse transcriptase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which drugs are used to treat Hep B

A
  • Lamivudine
  • Entecavir
  • Tenofovir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which drugs are used to treat Hep C

A
  • Sofosbuvir
  • Glecaprevir
  • Ledipasvir
  • Ribavirin
  • PEG-IFN alpha
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of Tenofovir

A
  • Reverse transcriptase inhibitor
  • analog of adenosine
  • incorporate into growing DNA strands and cause chain termination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of Entecavir

A
  • reverse transcriptase inhibitor
  • analog of guanosine
  • incorporate into growing DNA strands and cause chain termination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of Lamivudine

A
  • reverse transcriptase inhibitor
  • analog of cytidine
  • incorporate into growing DNA strands and cause chain termination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which Hep B drug has high rates of resistance

A
  • lamivudine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which Hep B drug has low rates of resistance

A
  • tenofovir

- entecavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

toxicity of Entecavir, Tenofovir

A
  • Acute tubular necrosis

- acute kidney injury in PCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

toxicity of tenofovir only

mechanism

A
  • osteoporosis

- reduced reabsorption of PO4 in PCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which are the first line monotherapies for both acute and chronic Hep B infections

A
  • Tenofovir

- Entecavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which hep B drug is not used as a monotherpay due to resistance

A
  • Lamivudine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NS5B is what

inhibitors end with which suffix

A
  • RNA polymerase
  • buvir

FLIP THE P UPSIDE DOWN TO MAKE A b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NS3A/4 is what

inhibitors end with which suffix

A
  • protease
  • previr

protease - previr

17
Q

NS5A is what

inhibitors end with which suffix

A
  • viral assembly
  • asvir

assembly - asvir

18
Q

MOA of sofosbuvir

A
  • NS5B RNA polymerase inhibitor
19
Q

MOA of Gleprevir

A
  • NS3/4A protease inhibitor
20
Q

MOA of Ledipasvir

A
  • NS5A assembly inhibitor
21
Q

drug interaction with sofosbuvir

mechanism

A
  • Amiodarone
  • compete with binding to albumin
  • increased free amiodarone
  • bradycardia, heart block
22
Q

Don’t use NS3/4 protease inhibitors (Glecaprevir) with which condition

A
  • decompensated cirrhosis
23
Q

drug interaction with NS5A inhibitors (Ledapasvir)

A
  • PPIs may reduce effectiveness
24
Q

MOA of ribavirin

A
  • guanosine analog

- interferes with Hep C RNA synthesis and induces mutations

25
MOA of monophosphate of ribavirin
- inhibits GTP synthesis
26
MOA of triphosphate of ribavirin
- inhibits RNA replication | - incorporates producing a defective genome
27
ribavirin for Hep C is administered how
- orally
28
distribution of ribavirin for Hep C
- concentrates in RBCs
29
use caution with ribavirin for Hep C in patients with
- renal insufficiency
30
toxicities of ribavirin
- hemolytic anemia | - teratogenic, embryotoxic
31
can pregnant women care for someone on aerosolized ribavirin what happens if a women does
- no | - birth control for 7 months
32
why do you add polyethylene glycol to IFN
- stabilize it | - make it more effective in the body
33
how do we give PEG-IFN alpha
- subcutaneously
34
toxicity of PEG-IFNalpha
- depression, anxiety, other neuropsychiatric effects
35
how do we give Hep C to avoid development of resistance
- give in combinations
36
Lepidasvir + sofosbuvir protects against what Hep C types
- 1, 4, 5, 6
37
Glecaprevir + pibrentasvir protects against what Hep C types
1, 2, 3, 4, 5, 6